Glutaminase is likely the rate-limiting enzyme for glutamine consumption in cancer cells and increased glutaminase activity by Rho GTPase through a NF-κB-dependent mechanism was described as a process involved in meeting the elevated glutamine demand in cancer cells [92]. Here, NFKB1 is linked to cancer.